Based on the advanced technology platform, Creative Proteomics provides ribosome profiling sequencing (Ribo-seq), m6A sequencing (m6A-seq) and RNA sequencing (RNA-seq) services, and offers integrated Riboseq-m6Aseq-RNAseq analysis. We can provide you with a one-stop service from experimental design, sample detection, independent omics data analysis to integrative analysis to meet a variety of research needs.
N6-adenylate methylation (m6A) is the most prevalent internal modification of eukaryotic mRNAs, and studies have shown that m6A modifications are present in approximately one-third of human and mouse mRNAs. m6A regulates RNA editing, translation and degradation, thereby affecting mRNA stability and regulating protein-RNA interactions, and is widely involved in mammalian development, immunity, tumorigenesis, metastasis, stem cell differentiation and other life processes. It is widely involved in mammalian development, immunity, tumorigenesis and metastasis, stem cell differentiation and other life processes. Since m6A can regulate the translation of genes, it is possible to integrate translatome technology (Ribo-seq) and m6A detection technology to conduct systematic and comprehensive studies.
Creative Proteomics provides you with Ribosome profiling sequencing (Ribo-seq), m6A sequencing (m6A-seq) and RNA sequencing (RNA-seq) services. In addition, we provide integrative analysis services of Riboseq-m6Aseq-RNAseq, seamlessly connecting your experiments to provide powerful insights into the evidence of complex life activity mechanisms.
Creative Proteomics will provide you with a detailed report, including:
Creative Proteomics relies on advanced platforms and cutting-edge technologies to provide omics services to customers around the world, and provide accurate and detailed analysis reports. In addition, we also provide multi-omics integrated analysis services. If you want to know more, please contact us, Creative Proteomics can be trusted.
Welcome to Consult
Creative Proteomics, your unparalleled center of excellence in sequencing, mass spectrometry, and bioinformatics analysis platforms, is elevating the landscape of research. Our seamless integration of these cutting-edge capabilities ensures that clients receive extraordinary multi-omics joint analysis services.